The Ontology for Medicinal Products
The ISO standards for Identification of Medicinal Products (IDMP) provide an internationally accepted framework to uniquely identify and describe medicinal products. Driven by regulatory requirements, the role of IDMP is to align the pharmaceutical industry on data standards for product and substance information. Realization of the full potential of IDMP depends on self-describing data to counteract diverse, non-standard IDMP implementations.
However, today’s IMDP implementations are built in silos and have already created inconsistencies of interpretation. Without an IDMP Ontology, the risk is that the envisioned IMDP benefits and cost savings are not fully realized. Furthermore, IDMP standards become mandatory for drug submissions in 2023.
Working in collaboration with numerous participating organizations, we will augment the existing IDMP standardization efforts with an IDMP Ontology that enables deep, semantic interoperability based on FAIR principles. This will ultimately enable entirely new ways of collaboration and enable early adopters to gain a competitive advantage in innovation, drug safety and overall operational efficiency.
Our Special Interest Groups (SIG) are led by industry leaders and EDM Council executives to explore key topics impacting data management. Learn about the latest developments, or get more involved on committees and working groups.
Join other professionals to learn and collaborate on graph solutions and uses
Learn more about the project, its objectives and downloads
Access the OWL ontology built on the ISO standards for IDMP
Explore EDM Council’s initiatives in Open Knowledge Graph (OKG)
A group of pharmaceutical representatives started the initiative to create the IDMP Ontology and selected Pistoia Alliance for the management and organization of the project. EDM Council, through its Open Knowledge Graph and Innovation Lab, is providing the governance and hosting of the ontology.